New York, NY (PRWEB) March 28, 2014
The prescription drug safety center DrugNews.net is announcing new information on the site for patients taking testosterone replacement therapies, or “low-T” drugs. An industry-backed group is asking that recent studies suggesting a link with heart attacks be retracted*.
DrugNews provides the latest drug warnings, product recalls and lawsuit news to patients taking popular prescription drugs. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.
Last year, more than 5.5 million men filled prescriptions for low-T drugs like AndroGel, Axiron, Testim and AndroDerm**. However, recent studies question their safety.
The resource center has added a study from UCLA and the National Institute of Health this year finding men over 65 and those with a history of heart disease had double the rate of heart attack after starting testosterone therapy***.
In November, the American Medical Association also released data showing older men or those with prior heart disease had a 29% increased rate of heart attacks, stroke or death from low-T drugs****. The FDA has launched an investigation into testosterone drug heart attack, stroke and death risks based on the studies*****.
Now, DrugNews has learned the AndroGen Study Group, a group of physicians and researchers affiliated with the testosterone drug industry, has requested that the AMA study be retracted due to the classification of excluded patients*. However, the study’s authors stand by their results*.
A number of men have already filed a testosterone lawsuit in an Illinois federal court alleging testosterone drugs caused heart attack or stroke without warning**.
Lawyers are offering help to those affected. Anyone who suffered a heart attack or stroke after using a low-T drug like AndroGel, Axiron, Testim or AndroDerm is urged to visit DrugNews or speak with a lawyer about their legal rights as soon as possible. DrugNews only recommends lawyers who have already handled testosterone lawsuits.
For more information on the research, side effects and litigation news related to testosterone drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*MedPage Today, 3/26/14; medpagetoday.com/Endocrinology/GeneralEndocrinology/44952
**Bloomberg, 2/5/14; bloomberg.com/news/2014-02-05/abbott-labs-sued-by-five-men-claiming-androgel-injuries.html; Aurecchia v. AbbVie Inc., 14-cv-00772, U.S. Dist. Ct, Northern District of Illinois (Chicago); Marino v. AbbVie Inc., 14-cv-00777 U.S. Dist. Ct, Northern District of Illinois (Chicago)
***Public Library of Science, 1/29/14; plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805
****JAMA 11/5/13; media.jamanetwork.com/news-item/testosterone-therapy-following-coronary-angiography-associated-increased-risk-adverse-outcomes/
*****FDA, 1/31/14; http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery